QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-genfit-lowers-price-target-to-7

HC Wainwright & Co. analyst Brandon Folkes maintains Genfit (NASDAQ:GNFT) with a Buy and lowers the price target from $9...

 genfit-h1-eps-023-down-from-057-yoy-sales-40443m-down-from-65887m-yoy

Genfit (NASDAQ:GNFT) reported quarterly losses of $(0.23) per share. This is a 140.35 percent decrease over earnings of $0.57 p...

 dow-hits-record-high-as-fed-cuts-rates-investor-sentiment-improves-fear-index-remains-in-greed-zone

The CNN Money Fear and Greed index improved while remaining in the Greed zone on Friday. Dow and S&P 500 rose, Nasdaq surged.

 globus-maritime-firefly-aerospace-and-3-stocks-to-watch-heading-into-monday

U.S. stock futures down, Firefly Aerospace, PRA Group, Genfit, Globus Maritime, & Marygold Companies in focus.

 genfit-announces-discontinuation-of-its-vs-01-program-in-aclf-vs-01-development-refocused-on-ucd-says-following-discontinuation-of-our-vs-01-program-in-aclf-we-anticipate-a-substantial-reduction-in-our-operating-expenses

GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCDLille (France), Cambridge (Mas...

 hc-wainwright--co-assumes-genfit-at-buy-announces-price-target-of-9

HC Wainwright & Co. analyst Brandon Folkes assumes Genfit (NASDAQ:GNFT) with a Buy rating and announces Price Target of $9.

 genfit-fy-eps-006-up-from-062-yoy-sales-4074m-beat-1630m-estimate

Genfit (NASDAQ:GNFT) reported quarterly losses of $(0.06) per share. This is a 90 percent increase over losses of $(0.62) per s...

 genfit-finalizes-2025-oceanes-proposal-repurchase-at-eur-3200-per-bond-alternative-eur-060-consent-fee-for-remaining-holder

In conjunction with the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, GENFIT will reques...

 hc-wainwright--co-reiterates-buy-on-genfit-maintains-13-price-target

HC Wainwright & Co. analyst Ed Arce reiterates Genfit (NASDAQ:GNFT) with a Buy and maintains $13 price target.

 hc-wainwright--co-reiterates-buy-on-genfit-maintains-13-price-target

HC Wainwright & Co. analyst Ed Arce reiterates Genfit (NASDAQ:GNFT) with a Buy and maintains $13 price target.

 hc-wainwright--co-reiterates-buy-on-genfit-maintains-13-price-target

HC Wainwright & Co. analyst Ed Arce reiterates Genfit (NASDAQ:GNFT) with a Buy and maintains $13 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION